 | • レポートコード：MRC2304J0025 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、244ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界の中心静脈カテーテル（CVC）市場規模は、2021年1,974.93百万ドルから2022年に2,152.27百万ドルへと拡大、その後2027年までに年平均9.23％成長して3,355.22百万ドルに達する見通しです。本書は、中心静脈カテーテル（CVC）の世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別分析（移植ポート、非トンネル型中心静脈カテーテル、末梢挿入型中心静脈カテーテル、トンネル型中心静脈カテーテル）、デザイン別分析（ダブルルーメン型中心静脈カテーテル、マルチルーメン型中心静脈カテーテル、シングルルーメン型中心静脈カテーテル）、材料別分析（ポリウレタン、ゴム、シリコーン）、用途別分析（輸血、診断＆検査、薬剤管理、水分＆栄養管理）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、Amecath、AngioDynamics, Inc.、B. Braun Melsungen AG、Bactiguard AB、Becton, Dickinson and Company、Biosensors International Group, Ltd.、Cook Group、Edwards Lifesciences Corporation、ICU Medical, Inc.、Insung Medicalなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の中心静脈カテーテル（CVC）市場規模：製品タイプ別 - 移植ポートの市場規模 - 非トンネル型中心静脈カテーテルの市場規模 - 末梢挿入型中心静脈カテーテルの市場規模 - トンネル型中心静脈カテーテルの市場規模 ・世界の中心静脈カテーテル（CVC）市場規模：デザイン別 - ダブルルーメン型中心静脈カテーテルの市場規模 - マルチルーメン型中心静脈カテーテルの市場規模 - シングルルーメン型中心静脈カテーテルの市場規模 ・世界の中心静脈カテーテル（CVC）市場規模：材料別 - ポリウレタンの市場規模 - ゴムの市場規模 - シリコーンの市場規模 ・世界の中心静脈カテーテル（CVC）市場規模：用途別 - 輸血における市場規模 - 診断＆検査における市場規模 - 薬剤管理における市場規模 - 水分＆栄養管理における市場規模 ・世界の中心静脈カテーテル（CVC）市場規模：地域別 - 南北アメリカの中心静脈カテーテル（CVC）市場規模 アメリカの中心静脈カテーテル（CVC）市場規模 カナダの中心静脈カテーテル（CVC）市場規模 ブラジルの中心静脈カテーテル（CVC）市場規模 ... - アジア太平洋の中心静脈カテーテル（CVC）市場規模 日本の中心静脈カテーテル（CVC）市場規模 中国の中心静脈カテーテル（CVC）市場規模 インドの中心静脈カテーテル（CVC）市場規模 韓国の中心静脈カテーテル（CVC）市場規模 台湾の中心静脈カテーテル（CVC）市場規模 ... - ヨーロッパ/中東/アフリカの中心静脈カテーテル（CVC）市場規模 イギリスの中心静脈カテーテル（CVC）市場規模 ドイツの中心静脈カテーテル（CVC）市場規模 フランスの中心静脈カテーテル（CVC）市場規模 ロシアの中心静脈カテーテル（CVC）市場規模 ... - その他地域の中心静脈カテーテル（CVC）市場規模 ・競争状況 ・企業情報 |
The Global Central Venous Catheters Market size was estimated at USD 1,974.93 million in 2021 and expected to reach USD 2,152.27 million in 2022, and is projected to grow at a CAGR 9.23% to reach USD 3,355.22 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Central Venous Catheters to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Implanted Ports, Non-tunneled Central Venous Catheters, Peripherally Inserted CVCs, and Tunneled Central Venous Catheters.
Based on Design, the market was studied across Double Lumen Central Venous Catheters, Multiple Lumen Central Venous Catheters, and Single Lumen Central Venous Catheters.
Based on Material, the market was studied across Polyurethane, Rubber, and Silicone.
Based on Application, the market was studied across Blood Transfusion, Diagnostics & Testing, Drug Administration, and Fluid & Nutrition Administration.
Based on End-User, the market was studied across Ambulatory Surgery Centers and Hospitals & Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Central Venous Catheters market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Central Venous Catheters Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Central Venous Catheters Market, including Amecath, AngioDynamics, Inc., B. Braun Melsungen AG, Bactiguard AB, Becton, Dickinson and Company, Biosensors International Group, Ltd., Cook Group, Edwards Lifesciences Corporation, ICU Medical, Inc., Insung Medical, KIMAL PLC, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Polymedicure, QMD, Teleflex Incorporated, VOGT Medical, Vygon SAS, and ZOLL Medical Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Central Venous Catheters Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Central Venous Catheters Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Central Venous Catheters Market?
4. What is the competitive strategic window for opportunities in the Global Central Venous Catheters Market?
5. What are the technology trends and regulatory frameworks in the Global Central Venous Catheters Market?
6. What is the market share of the leading vendors in the Global Central Venous Catheters Market?
7. What modes and strategic moves are considered suitable for entering the Global Central Venous Catheters Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population worldwide
5.1.1.2. Increasing healthcare and welfare expenditures
5.1.1.3. Popularity of antimicrobial catheters
5.1.2. Restraints
5.1.2.1. High cost of central venous catheters
5.1.3. Opportunities
5.1.3.1. Development of new central venous catheters
5.1.3.2. Government initiatives to improve the accessibility of cancer treatments
5.1.4. Challenges
5.1.4.1. Complications associated with prolonged use of central vein approaches
5.2. Cumulative Impact of COVID-19
6. Central Venous Catheters Market, by Product Type
6.1. Introduction
6.2. Implanted Ports
6.3. Non-tunneled Central Venous Catheters
6.4. Peripherally Inserted CVCs
6.5. Tunneled Central Venous Catheters
7. Central Venous Catheters Market, by Design
7.1. Introduction
7.2. Double Lumen Central Venous Catheters
7.3. Multiple Lumen Central Venous Catheters
7.4. Single Lumen Central Venous Catheters
8. Central Venous Catheters Market, by Material
8.1. Introduction
8.2. Polyurethane
8.3. Rubber
8.4. Silicone
9. Central Venous Catheters Market, by Application
9.1. Introduction
9.2. Blood Transfusion
9.3. Diagnostics & Testing
9.4. Drug Administration
9.5. Fluid & Nutrition Administration
10. Central Venous Catheters Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals & Clinics
11. Americas Central Venous Catheters Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Central Venous Catheters Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Central Venous Catheters Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Amecath
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. AngioDynamics, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. B. Braun Melsungen AG
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bactiguard AB
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Becton, Dickinson and Company
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Biosensors International Group, Ltd.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Cook Group
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Edwards Lifesciences Corporation
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. ICU Medical, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Insung Medical
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. KIMAL PLC
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Lepu Medical Technology(Beijing)Co.,Ltd.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Medtronic PLC
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Polymedicure
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. QMD
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Teleflex Incorporated
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. VOGT Medical
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Vygon SAS
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. ZOLL Medical Corporation
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing